Single-cells:
proven | viable | pure
Ensuring clonality in cell line development is gaining more and more importance and attention by regulatory authorities. Additionally, high cell viability and the prevention of cross-contamination are necessary for successfully generating a high number of clones.
This webinar will illustrate a new technology for automatically isolating single cells: the single-cell printer. It can be used for all common cell types used in cell line development and helps you to meet your requirements, especially achieving a very high rate of clonal recovery.
What this webinar will cover:
Presented by
Jonas Schoendube (M.Sc.),
CEO cytena GmbH
Jonas Schoendube holds a B.Sc. in Mechanical Engineering and a M.Sc. in Micro and Nano Systems from ETH Zurich. He performed his Master's thesis at Stanford University, USA. He is expert in micro-fluidics, micro-fabrication and single-cell isolation.
Jonas and his colleague Andre Gross developed the single-cell printing technology.
Working with customers in the pharmaceutical industry, Jonas is very familiar with issues of evidence of clonality, cross-contamination and cell viability in cell culture.
